BackCan-Fite Biopharma Overview
Can-Fite Biopharma Ltd - ADR

Can-Fite Biopharma Target Price

Where could CANF trade next? Consensus target price: $6.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$2.36

Average Target Price

$6.50175.4% upside

2 analysts in the last 4 months

High: $8 | Low: $5

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-02H.C. Wainwright$8239% upsideOpen
2026-05-12H.C. WainwrightSwayampakula Ramakanth$5111.9% upsideOpen
2025-04-15Industrial Alliance SecuritiesJames Molloy$903713.6% upsideOpen
2024-07-17EF HuttonJason Kolbert$2008374.6% upsideOpen

Can-Fite Biopharma (CANF) FAQ

The latest target price for CANF is $6.5. Investors often review this figure alongside Can-Fite Biopharma's historical trend and sector peers before judging valuation or financial health.

Can-Fite Biopharma trades near $2.36 while the consensus target sits at $6.5 (175.4% upside). Targets are estimates based on earnings forecasts and valuation models; they change when analysts update ratings or revise models. Compare the average with the high and low targets for a fuller picture.

After noting CANF's target price ($6.5), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Can-Fite Biopharma's target price against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.